Analyst Research

Report Title Price
Provider: S&P Capital IQ Factual Report
$150.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CryoLife Inc Reaffirms FY 2013 Guidance-Conference Call


Saturday, 20 Apr 2013 02:00pm EDT 

CryoLife Inc reaffirmed fiscal 2013 guidance and expects revenues to be between $139 million and $143 million and expect earnings per share (EPS) for fiscal 2013 to be between $0.25 and $0.28. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $142 million and EPS of $0.27 for fiscal 2013. 

Company Quote

10.17
-0.04 -0.39%
22 Sep 2014